Segment Information

3 Months Ended

Sep. 30, 2025

Segment Reporting [Abstract]

Segment Information [Text Block]

Note 8. Segment Information

The Company operates in one operating segment, and therefore one reportable segment, focused on the development, manufacturing, marketing, and distribution of a broad line of medical products for the orthopedic, physical therapy and similar markets. This determination, that the Company operates as a single operating segment, is consistent with the financial information regularly reviewed by the Chief Operating Decision Maker ("CODM") for purposes of evaluating performance, allocating resources, and planning and forecasting future periods. The Company's Chief Executive Officer ("CEO") is the CODM.

The accounting policies for the single operating segment are the same as those described in "Note 1-Basis of Presentation and Summary of Significant Accounting Policies." The CODM uses net loss based on net loss that is reported on the condensed consolidated statement of operations to allocate resources (including employees, property, and financial resources), predominantly during the annual budget and forecasting process. Selling, general, and administrative expenses are the sole significant expense category reviewed by the CODM at the segment level; no other segment expenses are material or separately evaluated. All revenues are generated in the US.

Asset information is not reported to or reviewed by the CODM to allocate resources, and therefore, the Company has not disclosed asset information for its segment.

The following table presents segment revenue and significant expenses regularly reviewed by the CODM for the three months ended September 30, 2025 and 2024:

		Three Months Ended September 30,
		2025			2024
Net sales	$	7,024,027		$	7,602,249
Cost of sales		5,292,398			5,621,442
Gross profit		1,731,629			1,980,807
Selling, general, and administrative expenses		1,820,092			2,231,803
Operating loss		(88,463	)		(250,996	)
Other (expense) income:
Interest expense, net		(103,366	)		(106,348	)
Net other expense		(103,366	)		(106,348	)
Loss before income taxes		(191,829	)		(357,344	)
Income tax provision		(10,028	)		(9,304	)
Net loss	$	(201,857	)	$	(366,648	)

Accordingly, the Company manages its operations as a single operating and reportable segment, and the condensed consolidated financial statements and notes thereto are presented as a single reportable segment.